[go: up one dir, main page]

IS6863A - Ný himnuhúð - Google Patents

Ný himnuhúð

Info

Publication number
IS6863A
IS6863A IS6863A IS6863A IS6863A IS 6863 A IS6863 A IS 6863A IS 6863 A IS6863 A IS 6863A IS 6863 A IS6863 A IS 6863A IS 6863 A IS6863 A IS 6863A
Authority
IS
Iceland
Prior art keywords
pharmaceutical formulations
new membrane
modified release
film
achievement
Prior art date
Application number
IS6863A
Other languages
English (en)
Inventor
Johan Pontus de Verdier Hjärtstam Lars
Löfroth Jan-Erik
Schantz Staffan
Welin Anders
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0104327A external-priority patent/SE0104327D0/xx
Priority claimed from SE0104328A external-priority patent/SE0104328D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS6863A publication Critical patent/IS6863A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Piezo-Electric Transducers For Audible Bands (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Surface Treatment Of Glass Fibres Or Filaments (AREA)
IS6863A 2001-12-19 2003-07-01 Ný himnuhúð IS6863A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0104327A SE0104327D0 (sv) 2001-12-19 2001-12-19 New film coating
SE0104328A SE0104328D0 (sv) 2001-12-19 2001-12-19 New film coating
PCT/GB2002/005739 WO2003051340A1 (en) 2001-12-19 2002-12-18 New film coating

Publications (1)

Publication Number Publication Date
IS6863A true IS6863A (is) 2003-07-01

Family

ID=26655630

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6863A IS6863A (is) 2001-12-19 2003-07-01 Ný himnuhúð

Country Status (25)

Country Link
US (2) US6827947B2 (is)
EP (2) EP1355633B1 (is)
JP (1) JP2005514386A (is)
KR (1) KR20040065989A (is)
CN (1) CN100341491C (is)
AT (1) ATE287259T1 (is)
AU (2) AU2002361447B2 (is)
BR (1) BR0206441A (is)
CA (1) CA2435729C (is)
CZ (1) CZ20031970A3 (is)
DE (2) DE20220902U1 (is)
DK (1) DK1355633T3 (is)
ES (1) ES2233876T3 (is)
HU (1) HUP0303886A3 (is)
IL (1) IL156998A0 (is)
IS (1) IS6863A (is)
MX (1) MXPA03007156A (is)
NO (1) NO320358B1 (is)
NZ (1) NZ526926A (is)
PL (1) PL362378A1 (is)
PT (1) PT1355633E (is)
RU (1) RU2323717C2 (is)
SI (1) SI1355633T1 (is)
SK (1) SK9132003A3 (is)
WO (1) WO2003051340A1 (is)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100200D0 (sv) * 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
DE20220902U1 (de) * 2001-12-19 2004-06-09 Astrazeneca Ab Neuer Filmüberzug
ES2627842T3 (es) 2002-02-21 2017-07-31 Valeant Pharmaceuticals Luxembourg S.À.R.L. Formas de dosificación de liberación controlada
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
SE0202353D0 (sv) * 2002-08-01 2002-08-01 Astrazeneca Ab New film coating
US7080545B2 (en) * 2002-10-17 2006-07-25 Advanced Technology Materials, Inc. Apparatus and process for sensing fluoro species in semiconductor processing systems
AU2004285284B2 (en) * 2003-10-31 2010-03-25 Hexal Ag A process for the preparation of an active-ingredient-containing formulation with a coating
WO2005084636A2 (en) * 2004-02-27 2005-09-15 Ranbaxy Laboratories Limited A process for the preparation of controlled-release pharmaceutical composition of metoprolol
JP2005306778A (ja) * 2004-04-21 2005-11-04 Basf Ag 徐放性製剤及びその製造方法
US7838031B2 (en) * 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
DE102004035936A1 (de) * 2004-07-23 2006-03-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
KR20080041669A (ko) * 2005-07-28 2008-05-13 샤이어 엘엘씨 매일 단일 투여량 형태로 투여하기에 적합한 구안파신의약학적 제형물/조성물
AU2005338350A1 (en) * 2005-11-18 2007-05-24 Solapharm, Inc. Segmented pharmaceutical dosage forms
DE102005060393A1 (de) * 2005-12-16 2007-06-21 Add Advanced Drug Delivery Technologies Ltd. Orales Präparat mit kontrollierter Freisetzung
US20080118570A1 (en) * 2006-11-20 2008-05-22 Zhi Liu Polymer coated drug-ion exchange resins and methods
US20100303920A1 (en) * 2009-05-27 2010-12-02 Johan Hjartstam Aqueous Film Coating Composition / 841
CA2769652A1 (en) 2009-08-05 2011-02-10 Idenix Pharmaceuticals, Inc. Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv
WO2011056764A1 (en) 2009-11-05 2011-05-12 Ambit Biosciences Corp. Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
TW201136942A (en) 2009-12-18 2011-11-01 Idenix Pharmaceuticals Inc 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors
IL210279A0 (en) 2009-12-25 2011-03-31 Dexcel Pharma Technologies Ltd Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients
WO2011094890A1 (en) 2010-02-02 2011-08-11 Argusina Inc. Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
WO2011112689A2 (en) 2010-03-11 2011-09-15 Ambit Biosciences Corp. Saltz of an indazolylpyrrolotriazine
AU2011296078B2 (en) 2010-09-01 2015-06-18 Ambit Biosciences Corporation An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
MX2013002383A (es) 2010-09-01 2013-07-05 Ambit Biosciences Corp Sales bromhidrato de una pirazolilaminoquinazolina.
WO2012078649A1 (en) 2010-12-06 2012-06-14 Follica, Inc. Methods for treating baldness and promoting hair growth
WO2012080050A1 (en) 2010-12-14 2012-06-21 F. Hoffmann-La Roche Ag Solid forms of a phenoxybenzenesulfonyl compound
US9393255B2 (en) 2011-01-31 2016-07-19 Celgene Corporation Pharmaceutical compositions of cytidine analogs and methods of use thereof
AR085352A1 (es) 2011-02-10 2013-09-25 Idenix Pharmaceuticals Inc Inhibidores macrociclicos de serina proteasa, sus composiciones farmaceuticas y su uso para tratar infecciones por hcv
US20120252721A1 (en) 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
BR112013027484A8 (pt) * 2011-06-17 2022-07-05 Evonik Roehm Gmbh Composição farmacêutica ou nutracêutica com resistência gástrica, e uso de um polímero de (met)acrilato
US9844511B2 (en) * 2011-06-17 2017-12-19 Evonik Roehm Gmbh Coating composition suitable for pharmaceutical or nutraceutical dosage forms
SG11201405761WA (en) 2012-03-16 2014-10-30 Axikin Pharmaceuticals Inc 3,5-diaminopyrazole kinase inhibitors
CA2900781A1 (en) 2013-02-13 2014-08-21 Evonik Rohm Gmbh Multiparticulate pharmaceutical composition comprising a multitude of two kinds of pellets
NZ631142A (en) 2013-09-18 2016-03-31 Axikin Pharmaceuticals Inc Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
WO2015042375A1 (en) 2013-09-20 2015-03-26 Idenix Pharmaceuticals, Inc. Hepatitis c virus inhibitors
JP5846185B2 (ja) 2013-11-21 2016-01-20 大日本印刷株式会社 貫通電極基板及び貫通電極基板を用いた半導体装置
US20170066779A1 (en) 2014-03-05 2017-03-09 Idenix Pharmaceuticals Llc Solid forms of a flaviviridae virus inhibitor compound and salts thereof
CN106661027B (zh) 2014-03-20 2019-12-24 卡佩拉医疗公司 苯并咪唑衍生物作为erbb酪氨酸激酶抑制剂用于治疗癌症
SG11201607706SA (en) 2014-03-20 2016-10-28 Capella Therapeutics Inc Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer
JP6626492B2 (ja) * 2014-07-09 2019-12-25 サン ファーマシューティカル インダストリーズ リミテッドＳｕｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｉｎｄｕｓｔｒｉｅｓ Ｌｔｄ． コハク酸メトプロロールのカプセル剤形
WO2016042565A1 (en) * 2014-09-16 2016-03-24 Suresh Pareek Extended release 'formulation of metoprolol
EA032473B1 (ru) 2014-12-23 2019-05-31 Аксикин Фармасьютикалз, Инк. 3,5-диаминопиразоловые ингибиторы киназы
AU2017290887B2 (en) * 2016-06-30 2021-08-05 Beckman Coulter, Inc. Chemiluminescent substrates
ES3040411T3 (en) 2018-03-22 2025-10-30 Incarda Therapeutics Inc A novel method to slow ventricular rate
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB878234A (en) 1958-12-18 1961-09-27 Roehm & Haas Gmbh Pharmaceutical coating compositions
DE1228757B (de) 1962-06-28 1966-11-17 Haessle Ab Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen
US3341338A (en) 1965-05-28 1967-09-12 Union Carbide Corp Polysiloxane polish formulations
DE2031871C3 (de) 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4916171A (en) 1984-07-25 1990-04-10 Rohm And Haas Company Polymers comprising alkali-insoluble core/alkali-soluble shell and copositions thereof
SE8404467D0 (sv) * 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
SE450087B (sv) 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
US5246714A (en) 1985-10-11 1993-09-21 Aktiebolaget Hassle Drug preparation
SE455836B (sv) 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
US4975283A (en) 1985-12-12 1990-12-04 Bristol-Myers Squibb Company Stabilized enteric coated aspirin granules and process for preparation
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
US4871546A (en) * 1987-06-29 1989-10-03 Sandoz Pharm. Corp. Gastrointestinal protective coating formulations
EP0313845A1 (en) 1987-09-29 1989-05-03 Warner-Lambert Company Stabilization of enteric coated dosage form
US5292522A (en) * 1989-06-20 1994-03-08 Rohm Gmbh Aqueous film coating agent for solid medicaments
FR2655266B1 (fr) 1989-12-05 1992-04-03 Smith Kline French Lab Compositions pharmaceutiques a base de cimetidine.
GB9200607D0 (en) 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US5376384A (en) 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
PT621032E (pt) 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
CA2117546A1 (en) * 1993-08-27 1995-02-28 Takateru Muraoka Medical adhesive sheet
DE4444051A1 (de) 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
US5871776A (en) 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
DE19615812A1 (de) * 1996-04-20 1997-10-23 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation
US6046177A (en) 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
US6627223B2 (en) * 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
SE0100200D0 (sv) * 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
DE20220902U1 (de) * 2001-12-19 2004-06-09 Astrazeneca Ab Neuer Filmüberzug
US20030175342A1 (en) * 2002-03-14 2003-09-18 Karl Kolter Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
SE0202353D0 (sv) 2002-08-01 2002-08-01 Astrazeneca Ab New film coating

Also Published As

Publication number Publication date
IL156998A0 (en) 2004-02-08
AU2002361447A1 (en) 2003-06-30
CZ20031970A3 (cs) 2003-10-15
US7815938B2 (en) 2010-10-19
HUP0303886A2 (hu) 2004-05-28
NZ526926A (en) 2006-02-24
EP1477163A1 (en) 2004-11-17
DE20220902U1 (de) 2004-06-09
BR0206441A (pt) 2003-12-30
WO2003051340A1 (en) 2003-06-26
NO20033653L (no) 2003-10-10
DE60202662T2 (de) 2006-01-05
HK1058312A1 (en) 2004-05-14
US20040030033A1 (en) 2004-02-12
CN1503663A (zh) 2004-06-09
EP1355633B1 (en) 2005-01-19
MXPA03007156A (es) 2003-11-18
AU2002361447B2 (en) 2008-05-29
CN100341491C (zh) 2007-10-10
PL362378A1 (en) 2004-10-18
SK9132003A3 (en) 2004-02-03
DE60202662D1 (de) 2005-02-24
KR20040065989A (ko) 2004-07-23
ATE287259T1 (de) 2005-02-15
CA2435729C (en) 2005-12-13
SI1355633T1 (en) 2005-06-30
HUP0303886A3 (en) 2005-05-30
DK1355633T3 (da) 2005-04-04
US6827947B2 (en) 2004-12-07
ES2233876T3 (es) 2005-06-16
AU2008207594A1 (en) 2008-09-18
RU2003125371A (ru) 2005-02-10
NO320358B1 (no) 2005-11-28
RU2323717C2 (ru) 2008-05-10
CA2435729A1 (en) 2003-06-26
US20050089574A1 (en) 2005-04-28
NO20033653D0 (no) 2003-08-18
PT1355633E (pt) 2005-05-31
JP2005514386A (ja) 2005-05-19
EP1355633A1 (en) 2003-10-29

Similar Documents

Publication Publication Date Title
IS6863A (is) Ný himnuhúð
NZ526792A (en) Film coating composition for controlled release from pharmaceutical formulations
DK0868912T3 (da) Anvendelse af redispergerbare polymerpulvere eller polymergranulater til coating af farmaceutiske eller agrokemiske applikationsformer
BR0013391A (pt) Uso do receptor baff (bcma) como um agente imunoregulador
ATE241341T1 (de) Stabilisierte pharmazeutische zusammensetzung
DE60206078D1 (de) Pharmazeutische komposition für verlängerte/langanhaltende freisetzung eines therapeutisch aktiven wirkstoffes
BRPI0509659A8 (pt) Processo para a preparação de uma composição de polímero de dispersão aquosa
CA2325900A1 (fr) Composition cosmetique comprenant un polymere aux caracteristiques particulieres et un polymere epaississant
MX9206952A (es) Polvo de dispercion redispersable a partir de un copolimerizado de acetato de vinilo de n-vinilpirrolidona su preparcion y su empleo
WO2009028583A1 (ja) コーティング製剤の製造方法
AR069665A1 (es) Composiciones para modelar el cabello y metodos de uso
EP1637120A3 (en) Aqueous, non-alcoholic liquid powder formulations
DK1636318T3 (da) Opsvulmende overtrækssammensætninger
DK1169032T3 (da) Ketoprofen-mikrogranuler, fremgangsmåde til fremstilling deraf og farmaceutiske præparater
ATE423179T1 (de) Amphiphile copolymerzusammensetzungen
WO2007041367A3 (en) Oral composition containing a salivation inducing agent
GB1296241A (is)
BR0311773A (pt) composição de revestimento tendo partìculas diluentes de cloreto de polivinila
ATE444739T1 (de) Polymerzusammensetzung sowie diese enthaltende darreichungsformen
SE0202353D0 (sv) New film coating
TW200627061A (en) Photosensitive composition, image-forming base material, image-forming material, and image-forming method
CO4940371A1 (es) Producto cosmetico removedor de tapones queratotonicos de la piel
BR0111504A (pt) Composições dilatáveis em água
SE0104327D0 (sv) New film coating
NO20044926L (no) Kopolymer, fremgangsmate for fremstilling og anvendelse som film ved belegging av farmasoytiske formuleringer.